- Home
- IDAI vs SXTP Comparison
IDAI vs SXTP Comparison
Compare IDAI & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- SXTP
- Stock Information
- Founded
- IDAI 2016
- SXTP 2010
- Country
- IDAI United States
- SXTP United States
- Employees
- IDAI N/A
- SXTP N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- IDAI Technology
- SXTP Health Care
- Exchange
- IDAI Nasdaq
- SXTP Nasdaq
- Market Cap
- IDAI 4.6M
- SXTP 4.3M
- IPO Year
- IDAI N/A
- SXTP 2023
- Fundamental
- Price
- IDAI $2.66
- SXTP $2.32
- Analyst Decision
- IDAI
- SXTP Buy
- Analyst Count
- IDAI 0
- SXTP 2
- Target Price
- IDAI N/A
- SXTP $7.00
- AVG Volume (30 Days)
- IDAI 37.6K
- SXTP 324.9K
- Earning Date
- IDAI 08-12-2025
- SXTP 08-13-2025
- Dividend Yield
- IDAI N/A
- SXTP N/A
- EPS Growth
- IDAI N/A
- SXTP N/A
- EPS
- IDAI N/A
- SXTP N/A
- Revenue
- IDAI $3,054,143.00
- SXTP $802,323.00
- Revenue This Year
- IDAI $65.46
- SXTP $95.50
- Revenue Next Year
- IDAI $12.00
- SXTP $80.78
- P/E Ratio
- IDAI N/A
- SXTP N/A
- Revenue Growth
- IDAI N/A
- SXTP 118.37
- 52 Week Low
- IDAI $1.43
- SXTP $1.41
- 52 Week High
- IDAI $18.75
- SXTP $35.99
- Technical
- Relative Strength Index (RSI)
- IDAI 66.87
- SXTP 50.64
- Support Level
- IDAI $1.90
- SXTP $1.91
- Resistance Level
- IDAI $2.62
- SXTP $2.55
- Average True Range (ATR)
- IDAI 0.21
- SXTP 0.24
- MACD
- IDAI 0.05
- SXTP -0.00
- Stochastic Oscillator
- IDAI 96.34
- SXTP 46.09
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.